MK-0000-145

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-145, covering 2015-10-12 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)